Position in GILD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$446,959
-$46,946 QoQ
Shares Held
3,207
-20.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2022CallValue
$2,532,570
CallShares
42,600
PutValue
$321,030
PutShares
5,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DRW Securities, LLC holds $13,449,884 across 5 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $446,959 | 3,207 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $493,905 | 4,024 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $541,569 | 4,879 | Shares | Other | 2025-11-14 | |
| 2025-03-31 | $433,073 | 3,865 | Shares | Other | 2025-05-15 | |
| 2024-03-31 | $612,077 | 8,356 | Shares | Other | 2024-05-14 | |
| 2023-09-30 | $289,942 | 3,869 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $328,857 | 4,267 | Shares | Other | 2023-08-15 | |
| 2022-03-31 | $2,532,570 | 42,600 | Call | Other | 2022-05-12 | |
| 2022-03-31 | $321,030 | 5,400 | Put | Other | 2022-05-12 | |
| 2021-06-30 | $275,302 | 3,998 | Shares | Other | 2021-08-12 | |
| 2020-09-30 | $357,402 | 5,656 | Shares | Other | 2020-11-12 | |
| 2020-03-31 | $517,563 | 6,923 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||